Review
doi: 10.1007/s10096-011-1337-4. Epub 2011 Jul 30.The impact of diabetes on the pathogenesis of sepsis
Affiliations
- PMID:21805196
- PMCID: PMC3303037
- DOI: 10.1007/s10096-011-1337-4
Item in Clipboard
Review
The impact of diabetes on the pathogenesis of sepsis
G C K W Koh et al. Eur J Clin Microbiol Infect Dis.2012 Apr.
Display options
Format
Display options
Format
Abstract
Diabetes is associated with an increased susceptibility to infection and sepsis. Conflicting data exist on whether the mortality of patients with sepsis is influenced by the presence of diabetes, fuelling the ongoing debate on the benefit of tight glucose regulation in patients with sepsis. The main reason for which diabetes predisposes to infection appears to be abnormalities of the host response, particularly in neutrophil chemotaxis, adhesion and intracellular killing, defects that have been attributed to the effect of hyperglycaemia. There is also evidence for defects in humoral immunity, and this may play a larger role than previously recognised. We review the literature on the immune response in diabetes and its potential contribution to the pathogenesis of sepsis. In addition, the effect of diabetes treatment on the immune response is discussed, with specific reference to insulin, metformin, sulphonylureas and thiazolidinediones.
Similar articles
- Association of diabetes and diabetes treatment with the host response in critically ill sepsis patients.van Vught LA, Scicluna BP, Hoogendijk AJ, Wiewel MA, Klein Klouwenberg PM, Cremer OL, Horn J, Nürnberg P, Bonten MM, Schultz MJ, van der Poll T.van Vught LA, et al.Crit Care. 2016 Aug 6;20(1):252. doi: 10.1186/s13054-016-1429-8.Crit Care. 2016.PMID:27495247Free PMC article.
- Oral antidiabetic agents: current role in type 2 diabetes mellitus.Krentz AJ, Bailey CJ.Krentz AJ, et al.Drugs. 2005;65(3):385-411. doi: 10.2165/00003495-200565030-00005.Drugs. 2005.PMID:15669880Review.
- Glucagon Reduces Neutrophil Migration and Increases Susceptibility to Sepsis in Diabetic Mice.Insuela DBR, Ferrero MR, Gonçalves-de-Albuquerque CF, Chaves ADS, da Silva AYO, Castro-Faria-Neto HC, Simões RL, Barja-Fidalgo TC, Silva PMRE, Martins MA, Silva AR, Carvalho VF.Insuela DBR, et al.Front Immunol. 2021 Jul 6;12:633540. doi: 10.3389/fimmu.2021.633540. eCollection 2021.Front Immunol. 2021.PMID:34295325Free PMC article.
- Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.Plosker GL, Figgitt DP.Plosker GL, et al.Pharmacoeconomics. 2004;22(6):389-411. doi: 10.2165/00019053-200422060-00005.Pharmacoeconomics. 2004.PMID:15099124Review.
- Drug treatments for managing cystic fibrosis-related diabetes.Onady GM, Stolfi A.Onady GM, et al.Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD004730. doi: 10.1002/14651858.CD004730.pub5.Cochrane Database Syst Rev. 2020.PMID:33075159Free PMC article.
Cited by
- Transient hyperglycaemia - an underestimated problem of paediatric oncohaematology.Irga N, Mysliwiec M, Osak M, Szmigiero-Kawko M, Adamkiewicz-Drozynska E, Jaworski R.Irga N, et al.Arch Med Sci. 2012 Sep 8;8(4):672-7. doi: 10.5114/aoms.2012.30291.Arch Med Sci. 2012.PMID:23056079Free PMC article.
- Cross-Cohort Microbiome Analysis of Salivary Biomarkers in Patients With Type 2 Diabetes Mellitus.Gao C, Guo Y, Chen F.Gao C, et al.Front Cell Infect Microbiol. 2022 Jan 25;12:816526. doi: 10.3389/fcimb.2022.816526. eCollection 2022.Front Cell Infect Microbiol. 2022.PMID:35145929Free PMC article.
- The diabetes pandemic and associated infections: suggestions for clinical microbiology.Toniolo A, Cassani G, Puggioni A, Rossi A, Colombo A, Onodera T, Ferrannini E.Toniolo A, et al.Rev Med Microbiol. 2019 Jan;30(1):1-17. doi: 10.1097/MRM.0000000000000155. Epub 2018 Nov 1.Rev Med Microbiol. 2019.PMID:30662163Free PMC article.
- Meta-analysis of peritoneal lavage in appendicectomy.Gammeri E, Petrinic T, Bond-Smith G, Gordon-Weeks A.Gammeri E, et al.BJS Open. 2018 Nov 29;3(1):24-30. doi: 10.1002/bjs5.50118. eCollection 2019 Feb.BJS Open. 2018.PMID:30734012Free PMC article.
- Risk factors and survival analysis of haemodialysis complicated with infective endocarditis.He YJ, Ye CS, Xu KY, Yang LL, Wang KL, Wang XM, Li MY, Wu Y, Ying QS, Wang M, Quan SJ, Yang X.He YJ, et al.Exp Ther Med. 2023 Mar 21;25(5):203. doi: 10.3892/etm.2023.11902. eCollection 2023 May.Exp Ther Med. 2023.PMID:37090071Free PMC article.
References
- Muller LMAJ, Gorter KJ, Hak E, Goudzwaard WL, Schellevis FG, Hoepelman AIM, Rutten GEHM. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis. 2005;41:281–288. - PubMed
- Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care. 2003;26:510–513. - PubMed
- Finfer S, Chittock DR, Su SY-S, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Hébert WR, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283–1297. - PubMed
- Stegenga ME, Vincent J-L, Vail GM, Xie J, Haney DJ, Williams MD, Bernard GR, van der Poll T. Diabetes does not alter mortality or hemostatic and inflammatory responses in patients with severe sepsis. Crit Care Med. 2010;38:539–545. - PubMed
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Medical